Archive - September 2019
Report shows no-deal Brexit is still a “highly uncertain environment”
NICE guidance could avert 1,000+ neonatal admissions
GSK announces positive real world data for Nucala
Suliqua launches in UK
Lenvima, Keytruda combo shows anti-tumour activity
GSK’s Zejula challenges AZ/Merck’s Lynparza in PARP inhibitor category
Hancock says UK will consider mandatory vaccinations
BMS plugs on with Opdivo plus Yervoy in first-line NSCLC
